Modulating mycobacterial envelope integrity for antibiotic synergy with benzothiazoles
Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains the deadliest bacterial infectious disease in the world (World Health Organization, 2022a). The current treatment for active drug-sensitive TB consists of six months with at …